FormWeb • tranexamic acid

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

tranexamic acid

tranexamic acid

Formulary Miscellaneous Programs Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Cyklokapron	SOLUTION, INTRAVENOUS	100 mg/mL
Lysteda	TABLET, ORAL	650 mg

VIEW MORE Hemostatics
CLASS

Comments:

Cyklokapron has been approved for use in OB hemorrhage cases.

Cyklokapron has been approved via nebulization for hemoptysis.

Lysteda is classified as formulary.

Reviewed: January 27, 2009, June 23, 2009, and July 27, 2010 (LYSTEDA).

Updated: November 19, 2013 (Trauma), January 28, 2014 (Ortho), 26 Sept 2017 (OB), December 2021 (Nebulization)

Last updated: Dec. 29, 2021

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.